Human kallikrein hK2 has low kininogenase activity while prostate-specific antigen (hK3) has none. 1997

D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
Laboratory of Hormonal Bioregulation, CHUL Research Center and Laval University, Sainte-Foy, Quebec, Canada.

In the present paper, we determined the kinin-releasing activity of human prostatic kallikrein hK2 and compared it to one of the kallikreins hK1 and prostate specific antigen (hK3). Kinin-like substances active on the rabbit jugular vein were progressively produced when nanomolar concentrations of hK2 were incubated with heated plasma. However in these experiments, hK1 appeared much more potent than hK2 while hK3 was totally inactive. When hK2 was incubated with purified high molecular weight kininogen, several peptides were generated as shown by the analysis on C18 reverse-phase HPLC. Kinin activity was localized exclusively in a small peak having an elution time identical to that of bradykinin while the only important peak obtained with hK1 corresponded to Lys-bradykinin. Finally, the rate of kinin production of hK2 was found to be more than a thousandfold lower than that of hK1. These experiments show that kallikreins hK2 has only a low kininogenase activity. However, it is not excluded that some of the peptides produced by hK2 action could have other types of biological activity.

UI MeSH Term Description Entries
D007610 Kallikreins Proteolytic enzymes from the serine endopeptidase family found in normal blood and urine. Specifically, Kallikreins are potent vasodilators and hypotensives and increase vascular permeability and affect smooth muscle. They act as infertility agents in men. Three forms are recognized, PLASMA KALLIKREIN (EC 3.4.21.34), TISSUE KALLIKREIN (EC 3.4.21.35), and PROSTATE-SPECIFIC ANTIGEN (EC 3.4.21.77). Kallikrein,Kininogenase,Callicrein,Dilminal,Kallidinogenase,Kalliginogenase,Kallikrein A,Kallikrein B',Kallikrein Light Chain,Kinin-Forming Enzyme,Padutin,alpha-Kallikrein,beta-Kallikrein,beta-Kallikrein B,Enzyme, Kinin-Forming,Kinin Forming Enzyme,Light Chain, Kallikrein,alpha Kallikrein,beta Kallikrein,beta Kallikrein B
D008297 Male Males
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017430 Prostate-Specific Antigen A glycoprotein that is a kallikrein-like serine proteinase and an esterase, produced by epithelial cells of both normal and malignant prostate tissue. It is an important marker for the diagnosis of prostate cancer. Kallikrein hK3,gamma-Seminoprotein,hK3 Kallikrein,Prostate Specific Antigen,Semenogelase,Seminin,Kallikrein, hK3,gamma Seminoprotein

Related Publications

D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
April 1998, The Journal of laboratory and clinical medicine,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
March 1999, Prostate cancer and prostatic diseases,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
May 1997, International journal of cancer,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
January 1999, Journal of andrology,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
April 1998, The Journal of urology,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
January 1996, The Prostate. Supplement,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
February 1997, The American journal of pathology,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
April 2002, Biochimica et biophysica acta,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
March 1997, Urology,
D Deperthes, and F Marceau, and G Frenette, and C Lazure, and R R Tremblay, and J Y Dubé
August 1998, Critical reviews in clinical laboratory sciences,
Copied contents to your clipboard!